文献速递呼吸道感染

胸片或CT用于COVID-19肺炎?模拟分诊环境下的比较研究

Chest radiography or computed tomography for COVID-19 pneumonia? Comparative study in a simulated triage setting.
PubMed 文献 · Eur Respir J · 2021-09-09

该研究在模拟分诊场景中,由5名临床观察者独立审阅300例疑似COVID-19肺炎患者的临床资料,分别结合重建胸片或高分辨率CT(HRCT)报告进行两轮盲法随机决策。结果显示重建胸片辅助方案的观察者间一致性为fair(Kendall's W=0.365, p<0.001),CT方案为good(Kendall's W=0.654, p<0.001);重建胸片辅助的阴性预测值(NPV)为31.4%,低于HRCT的77.9%。在影像表现不确定或典型时,两种影像的病变范围是唯一与死亡率相似关联的影像变量。结论提示胸片可安全辅助临床分诊,一线胸片联合按需HRCT的整合算法有助于优化管理。

要点

  • 重建胸片辅助分诊的观察者间一致性为fair,CT方案为good。
  • 重建胸片辅助的NPV为31.4%,低于HRCT的77.9%。
  • 胸片可安全辅助分诊,按需HRCT的整合算法可优化管理。

核心结论

  • 临床分诊可安全地由胸片辅助完成。
  • 一线胸片联合按需HRCT的整合算法有助于优化COVID-19的管理与预后判断。

研究设计与样本

  • 从高分辨率CT(HRCT)扫描重建胸片。
  • 5名临床观察者独立审阅300例疑似COVID-19肺炎患者的临床资料,结合重建胸片或HRCT报告,进行两轮盲法随机决策。

主要发现

  • 重建胸片辅助方案的观察者间一致性为fair(Kendall's W=0.365, p<0.001),CT方案为good(Kendall's W=0.654, p<0.001)。
  • 重建胸片辅助的NPV为31.4%,低于HRCT的77.9%。
  • 在影像表现不确定或典型时,重建胸片或HRCT上的病变范围是仅有的两个与死亡率相似关联的影像变量(校正多变量模型)。

临床怎么用

  • 在呼吸道分诊中可首先使用胸片辅助临床决策。
  • 根据胸片结果按需使用HRCT,以优化管理与预后判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: For the management of patients referred to respiratory triage during the early stages of the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) pandemic, either chest radiography or computed tomography (CT) were used as first-line diagnostic tools. The aim of this study was to compare the impact on the triage, diagnosis and prognosis of patients with suspected COVID-19 when clinical decisions are derived from reconstructed chest radiography or from CT. METHODS: We reconstructed chest radiographs from high-resolution CT (HRCT) scans. Five clinical observers independently reviewed clinical charts of 300 subjects with suspected COVID-19 pneumonia, integrated with either a reconstructed chest radiography or HRCT report in two consecutive blinded and randomised sessions: clinical decisions were recorded for each session. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and prognostic value were compared between reconstructed chest radiography and HRCT. The best radiological integration was also examined to develop an optimised respiratory triage algorithm. RESULTS: Interobserver agreement was fair (Kendall's W=0.365, p<0.001) by the reconstructed chest radiography-based protocol and good (Kendall's W=0.654, p<0.001) by the CT-based protocol. NPV assisted by reconstructed chest radiography (31.4%) was lower than that of HRCT (77.9%). In case of indeterminate or typical radiological appearance for COVID-19 pneumonia, extent of disease on reconstructed chest radiography or HRCT were the only two imaging variables that were similarly linked to mortality by adjusted multivariable models CONCLUSIONS: The present findings suggest that clinical triage is safely assisted by chest radiography. An integrated algorithm using first-line chest radiography and contingent use of HRCT can help optimise management and prognostication of COVID-19.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Sverzellati N, Ryerson CJ, Milanese G, et al. Chest radiography or computed tomography for COVID-19 pneumonia? Comparative study in a simulated triage setting. Eur Respir J. 2021. PMID: 33574070. doi:10.1183/13993003.04188-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。